Functional genomics of PCOS: from GWAS to molecular mechanisms
- PMID: 25600292
- PMCID: PMC4346470
- DOI: 10.1016/j.tem.2014.12.004
Functional genomics of PCOS: from GWAS to molecular mechanisms
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrinopathy characterized by increased ovarian androgen biosynthesis, anovulation, and infertility. PCOS has a strong heritable component based on familial clustering and twin studies. Genome-wide association studies (GWAS) identified several PCOS candidate loci including LHCGR, FSHR, ZNF217, YAP1, INSR, RAB5B, and C9orf3. We review the functional roles of strong PCOS candidate loci focusing on FSHR, LHCGR, INSR, and DENND1A. We propose that these candidates comprise a hierarchical signaling network by which DENND1A, LHCGR, INSR, RAB5B, adapter proteins, and associated downstream signaling cascades converge to regulate theca cell androgen biosynthesis. Future elucidation of the functional gene networks predicted by the PCOS GWAS will result in new diagnostic and therapeutic approaches for women with PCOS.
Keywords: GWAS; PCOS; genomics; hyperandrogenism; signaling; theca.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Figures
References
-
- Azziz R, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. The Journal of Clinical Endocrinology and Metabolism. 2006;91:4237–4245. - PubMed
-
- Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Human Reproduction. 2004;19:41–47. - PubMed
-
- De Leo V, et al. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome. Contraception. 2010;82:276–280. - PubMed
-
- Azziz R, et al. Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. Fertility and Sterility. 2003;79:932–937. - PubMed
-
- Azziz R, et al. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. The Journal of Clinical Endocrinology and Metabolism. 2001;86:1626–1632. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
